EE205 Cost-Effectiveness Analysis of Empagliflozin Versus Albiglutide Among Individuals with Type 2 Diabetes in the US
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.454
https://www.valueinhealthjournal.com/article/S1098-3015(22)00655-6/fulltext
Title :
EE205 Cost-Effectiveness Analysis of Empagliflozin Versus Albiglutide Among Individuals with Type 2 Diabetes in the US
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00655-6&doi=10.1016/j.jval.2022.04.454
First page :
Section Title :
Open access? :
No
Section Order :
10397